Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

398
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
398
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multilevel longitudinal study of patient-physician communication in later life proactive health behaviors.

Patient education and counseling·2026
Same author

A chronic whole cigarette smoke extract model reveals redox-mitochondrial adaptation in human lung epithelial and organoid models.

Experimental & molecular medicine·2026
Same author

Tumor lysis syndrome in a pediatric patient with Burkitt lymphoma following emergence from general anesthesia: a case report.

Journal of medical case reports·2026
Same author

The Role of Interpersonal Communication Competence in Enhancing Intraoperative Hand-Off Quality.

AORN journal·2026
Same author

Updated pediatric cardiopulmonary resuscitation: a comprehensive review of the 2025 guidelines.

Anesthesia and pain medicine·2026
Same author

Current recommendations for preventing residual neuromuscular blockade.

Anesthesia and pain medicine·2026

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.9K

Update on the evidence regarding maintenance therapy.

Jeong Eun Lee1, Chae-Uk Chung1

  • 1Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.

Tuberculosis and Respiratory Diseases
|February 14, 2014
PubMed
Summary

Maintenance therapy offers a novel approach for advanced non-small-cell lung cancer (NSCLC) by sustaining treatment benefits after initial chemotherapy. This strategy, including switch or continuous methods, shows promise in delaying disease progression and symptoms.

Keywords:
Carcinoma, Non-Small-Cell LungMaintenance Chemotherapy

More Related Videos

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

1.1K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.1K

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.9K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

1.1K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.1K

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trials

Background:

  • Advanced non-small-cell lung cancer (NSCLC) treatment traditionally involves sequential therapies.
  • First-line chemotherapy is standard, but optimal post-chemotherapy strategies remain an area of investigation.
  • Maintenance therapy has emerged as a novel paradigm to prolong clinical benefits.

Purpose of the Study:

  • To explore the concept and strategies of maintenance therapy in advanced non-small-cell lung cancer.
  • To review the potential benefits and ongoing debates surrounding its clinical application.
  • To assess the current recommendations and evidence for maintenance therapy in NSCLC.

Main Methods:

  • Review of existing literature and clinical trial data on maintenance therapy for advanced NSCLC.
  • Analysis of two primary maintenance strategies: switch maintenance and continuous maintenance.
  • Examination of evidence supporting tumor shrinkage, delayed symptom emergence, and overall survival.

Main Results:

  • Maintenance therapy aims to sustain a favorable clinical state after first-line chemotherapy.
  • Switch maintenance involves changing to a non-cross-resistant agent post-chemotherapy.
  • Continuous maintenance involves continuing a component of the initial regimen if disease is stable or improved.

Conclusions:

  • Maintenance therapy, despite ongoing debates on predictive parameters and quality of life, is recommended and shows benefit in advanced NSCLC.
  • It offers opportunities for additional treatment, sustained tumor shrinkage, and delayed symptom onset.
  • Further research may clarify optimal patient selection and long-term outcomes.